Biopharmaceutical
-
{
- All
- News
- Videos
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
- Tuesday June 20, 2023
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
www.ndtv.com
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
- Monday January 17, 2022
- India News | Reuters
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
www.ndtv.com
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
- Tuesday August 24, 2021
- India News | Reuters
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
www.ndtv.com
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
- Tuesday April 13, 2021
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
www.ndtv.com
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
- Friday December 11, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
www.ndtv.com
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
- Thursday December 10, 2020
- India News | Press Trust of India
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
www.ndtv.com
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
- Saturday September 19, 2020
- World News | Agence France-Presse
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
www.ndtv.com
-
This 24-Year-Old, Rihanna's Friend, Just Became An Overnight Billionaire
- Friday October 25, 2019
- World News | Taylor Telford, The Washington Post
Need a fail-proof recipe for instant billionaire? Just take the 24-year-old son of pharmaceutical moguls and add $3.8 billion in shares from the family business, gratis.
-
www.ndtv.com
-
Fire At Biocon's Research Subsidiary In Bengaluru, No Casualties Reported
- Tuesday December 13, 2016
- Bangalore News | Press Trust of India
A fire broke out on Monday at the premises of Syngene, the contract research subsidiary of Biocon, but there were no reports of any casualties.
-
www.ndtv.com
-
Time For India To Be Innovator Nation In Bio-Pharma: Expert
- Wednesday June 1, 2016
- India News | Press Trust of India
India has a "strong potential" to become a hub for biopharmaceutical innovation and the time has come for it to emerge as an innovator nation in this sector, a top industry leader has said.
-
www.ndtv.com
-
'Pharma Bro' Shkreli Arrested For Securities Fraud
- Friday December 18, 2015
- World News | Renae Merle and Carolyn Y. Johnson, The Washington Post
Martin Shkreli is a biotech executive who favors open-collar shirts over lab coats, the founder of a hedge fund who eschewed discretion by broadcasting his life on YouTube, a pill seller who made no bones about his power to raise the price of his medicines.
-
www.ndtv.com
-
Samsung Unit to Invest $736 Million in Manufacturing Plant
- Saturday November 28, 2015
- Thomson Reuters
Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglomerate steps up its expansion in the biopharmaceutical sector.
-
www.ndtvprofit.com
-
GE Healthcare to acquire PAA Laboratories
- Saturday November 26, 2011
- NDTV Correspondent
GE Healthcare on Tuesday said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedical research. "The acquisition of PAA Laboratories will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biop...
-
www.ndtvprofit.com
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
- Tuesday June 20, 2023
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
www.ndtv.com
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
- Monday January 17, 2022
- India News | Reuters
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
www.ndtv.com
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
- Tuesday August 24, 2021
- India News | Reuters
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
www.ndtv.com
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
- Tuesday April 13, 2021
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
www.ndtv.com
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
- Friday December 11, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
www.ndtv.com
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
- Thursday December 10, 2020
- India News | Press Trust of India
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
www.ndtv.com
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
- Saturday September 19, 2020
- World News | Agence France-Presse
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
www.ndtv.com
-
This 24-Year-Old, Rihanna's Friend, Just Became An Overnight Billionaire
- Friday October 25, 2019
- World News | Taylor Telford, The Washington Post
Need a fail-proof recipe for instant billionaire? Just take the 24-year-old son of pharmaceutical moguls and add $3.8 billion in shares from the family business, gratis.
-
www.ndtv.com
-
Fire At Biocon's Research Subsidiary In Bengaluru, No Casualties Reported
- Tuesday December 13, 2016
- Bangalore News | Press Trust of India
A fire broke out on Monday at the premises of Syngene, the contract research subsidiary of Biocon, but there were no reports of any casualties.
-
www.ndtv.com
-
Time For India To Be Innovator Nation In Bio-Pharma: Expert
- Wednesday June 1, 2016
- India News | Press Trust of India
India has a "strong potential" to become a hub for biopharmaceutical innovation and the time has come for it to emerge as an innovator nation in this sector, a top industry leader has said.
-
www.ndtv.com
-
'Pharma Bro' Shkreli Arrested For Securities Fraud
- Friday December 18, 2015
- World News | Renae Merle and Carolyn Y. Johnson, The Washington Post
Martin Shkreli is a biotech executive who favors open-collar shirts over lab coats, the founder of a hedge fund who eschewed discretion by broadcasting his life on YouTube, a pill seller who made no bones about his power to raise the price of his medicines.
-
www.ndtv.com
-
Samsung Unit to Invest $736 Million in Manufacturing Plant
- Saturday November 28, 2015
- Thomson Reuters
Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglomerate steps up its expansion in the biopharmaceutical sector.
-
www.ndtvprofit.com
-
GE Healthcare to acquire PAA Laboratories
- Saturday November 26, 2011
- NDTV Correspondent
GE Healthcare on Tuesday said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedical research. "The acquisition of PAA Laboratories will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biop...
-
www.ndtvprofit.com